One of the more intriguing aspects about the new wave of cell and gene therapies (CGT) coming onstream is that they are not just technologically…

Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park explores new ways of virtual collaboration that make our lives easier while…

During a global virtual press briefing on 19 March 2020, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)…

Barbara Lopez Kunz, CEO of the Drug Information Association (DIA) in the USA, outlines the association’s four key areas of focus – regulatory…

With sustainable development goals in mind, the global umbrella pharmaceutical association IFPMA has recently launched a platform that fosters…

We recently analysed the contents of 20 interviews conducted with country managers at multinational pharma companies in Sweden and found some…

Luxembourg has a young and ambitious life sciences community, which has identified four aspects of personalized medicine where the country has…

Patricia Ostrosky, general director of the Institute of Biomedical Research in Mexico, details current research subjects and calls for greater…

Lyonbiopole was established in 2005 as a cluster designed to support the local business community focused on infectious diseases and microbiology.…

In keeping with its reputation as a forerunner, the Dutch healthcare eco-system is currently reinventing itself to ensure it remains ahead of the game…

In an exclusive interview at the eyeforpharma Barcelona Summit 2016, GSK's Danie Du Plessis speaks out about patient-centricity and the growing role…

Paul Korte, General Manager for Janssen in the Netherlands, highlights the strategic move and leadership position taken up by Janssen in the oncology…